Koreatown's Seoul Medical Group Inc. and its subsidiary, Advanced Medical Management Inc., alongside their former president, Dr. Min Young Cha, will pay more than $62 million to resolve accusations of falsely inflating Medicare claims, the U.S. Department of Justice announced. This settlement stems from allegations that, from 2015 through 2021, the Koreatown-based medical provider and Dr. Cha were involved in submitting inaccurate diagnosis codes for non-existent spinal conditions to pocket higher payments from the Medicare Advantage program, which, in essence, robbed the federal government and its coffers, baits the taxpayer in fraudulent dealings.
Acting U.S. Attorney Joseph McNally underscored the commitment of his office to ensuring that healthcare providers are held accountable for unlawful misrepresentations to Medicare and other healthcare programs, signaling a clear intent to chase down and confront fraudulent acts within the healthcare system. This settlement reflects an iron will to secure the integrity of government healthcare programs, particularly the seniors who rely on the just administration of the Medicare Advantage program.
This healthcare charade, involving heartlessly riding the wave of false claims, has led to a separate but substantial $2.35 million slap of reality for Renaissance Imaging Medical Associates Inc., a Northridge-based radiology group that allegedly conspired with Seoul Medical Group by generating radiology reports intended to give a veneer of legitimacy to the bogus diagnoses. Altogether, these settlements send a harsh wake-up call to any healthcare providers tempted to distort the truth for financial gain that fraudulent conduct will be met with stiff penalties.
The justice system's gears have also showcased the role of whistleblowers in bringing such cases to light, as the civil settlement resolves claims initiated under the whistleblower provisions of the False Claims Act by Paul Pew, the former Vice President and Chief Financial Officer of Advanced Medical Management a mechanism that lets private parties sunder the veil of corporate secrecy to file actions on behalf of the United States, and potentially receive a cut of the recovery the amount of which in this case has yet to be decided. Assistant United States Attorney Karen Y. Paik and Trial Attorneys J. Jennifer Koh and Robbin O. Lee led the investigation into this matter.
